Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus

Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus Corneas

The goal of this clinical trial is to document corneal ectasia stability in patients with keratoconus diagnosis treated with personalized cross linking energy. The main questions it aims to answer are:

• Is it effective while using personalized (reduced) energy?
• Is it safe for corneas thinner than 400 microns? Participants will be treated with personalized energy corneal cross linking and posteriorly, will attend subsequent follow-up consults

Inclusion Criteria:

• Keratoconus diagnosed with corneal tomography/topography
• Thinnest point pachymetry below 400 microns

Exclusion Criteria:

• Previous corneal cross linking history
• Corneal scars not allowing best corrected visual acuity of 20/100 or better
• Previous corneal hydrops history
• Psychomotor retardation history